Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder

Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder

Mikhail Sergeevich Zastrozhin,1,2 Elena Anatolievna Grishina,3 Nataliya Petrovna Denisenko,3 Valentin Yurievich Skryabin,2 Dmitry Dmitrievich Markov,3 Ludmila Mikhailovna Savchenko,1 Evgeny Alekseevich Bryun,1,2 Dmitry Alekseevich Sychev4 1Department of Addictology, Russian Medical Academy of Contin...

Full description

Bibliographic Details
Main Authors: Zastrozhin MS, Grishina EA, Denisenko NP, Skryabin VY, Markov DD, Savchenko LM, Bryun EA, Sychev DA
Format: Article
Language:English
Published: Dove Medical Press 2018-06-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
pharmacogenetics
SSRIs
fluvoxamine
biotransformation
personalized medicine
CYP2D6
depressive disorders
alcohol addiction.
Online Access:https://www.dovepress.com/effects-of-cyp2d6-genetic-polymorphisms-on-the-efficacy-and-safety-of--peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/effects-of-cyp2d6-genetic-polymorphisms-on-the-efficacy-and-safety-of--peer-reviewed-article-PGPM

Similar Items